🔬 Science 2h ago · Gina Kolata, Rebecca Robbins and Carolyn Y. Johnson

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

New York Times Science
Latest science coverage from the NYT newsroom
View Channel →
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
Source ↗ 👁 0 💬 0
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

Comments (0)

Sign in to join the discussion

More Like This

Listen: What you need to know about the ‘explosive diarrhea’ parasite
Futurity · 2h ago
Bill Gates Announces That He Is the First Person Ever to Be Concerned About the Effects of AI
Futurism · 2h ago
Gut tissue may retain inflammatory 'memory' for more than a year
Medical Xpress - latest medical and health news stories · 2h ago
Chagas parasite's survival trick offers antimalarial-style target
Phys.org - latest science and technology news stories · 2h ago
Buried underwear shows land use is key to soil health
Phys.org - latest science and technology news stories · 2h ago
A new saliva test for endometriosis is in trials. What this and other new endo tests mean for you
Medical Xpress - latest medical and health news stories · 2h ago